BUD — Budget/Appropriations
Public Law 119-75, Consolidated Appropriations Act, 2026, Division B - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Provisions relating to NIH, Substance use research and indirect costs Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027, Provisions relating to NIH, Substance use research, indirect costs and Multi-year funding related issues
Lobbyists: EDWARD LONG; KATHERINE VANLANDINGHAM
Government entities lobbied: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE
HCR — Health Issues
Public Law 119-75, Consolidated Appropriations Act, 2026, Division B - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Provisions relating to NIH, Substance use research and indirect costs Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027, Provisions relating to NIH, Substance use research, indirect costs and Multi-year funding related issues H.R.7212, To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes, Entirety Public Law 119-26, HALT Fentanyl Act, Drug use research related issues Synthetic Fentanyl related issues Barriers to research resulting from DEA scheduling, Drug research related issues H.R.1802, Safeguard Pets, Animals, and Research Ethics (SPARE) Act , Entirety
Lobbyists: EDWARD LONG; KATHERINE VANLANDINGHAM
Government entities lobbied: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE